Huma Therapeutics (“Huma”), the global healthcare AI leader accelerating digital transformation across care and research, has announced two major milestones. The first is a global partnership agreement with Eckuity Capital to develop next-generation technology infrastructure—built on strong regulatory foundations—for the acquisition and launch of digital solutions in healthcare and research. The second is the acquisition of Aluna (also known as Knox Medical Diagnostics, Inc.), a leading U.S.-based company specializing in intelligent remote monitoring and management of respiratory diseases. To fuel its continued expansion, Huma is announcing partnership and investment with Eckuity Capital.
Read the full article: Huma Announces Partnership with Eckuity Capital to Accelerate M&A and Acquires Aluna //
Source: https://www.globenewswire.com/news-release/2025/05/16/3083203/0/en/Huma-Announces-Partnership-with-Eckuity-Capital-to-Accelerate-M-A-and-Acquires-Aluna.html